{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T11:32:26Z","timestamp":1794310346416,"version":"4.9.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003819","name":"Hubei Natural Science Foundation","doi-asserted-by":"crossref","award":["No.2023AFB170"],"award-info":[{"award-number":["No.2023AFB170"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 81902665"],"award-info":[{"award-number":["No. 81902665"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Science and Technology Plan Project of Shannan Municipal Science and Technology Bureau","award":["No.SNSBJKJJHXM2025025"],"award-info":[{"award-number":["No.SNSBJKJJHXM2025025"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-025-02909-1","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T06:25:28Z","timestamp":1755066328000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["High-risk human papillomavirus (hr-HPV) prevalence and abnormal cervical cytology in rural high-altitude communities: a population-based cross-sectional study in the Southern Tibetan Plateau, China (2023\u20132024)"],"prefix":"10.1186","volume":"22","author":[{"given":"Min","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeshi","family":"Lhamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsang","family":"Ch\u00f6dr\u00f6n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,13]]},"reference":[{"issue":"10167","key":"2909_CR1","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0140-6736(18)32470-X","volume":"393","author":"PA Cohen","year":"2019","unstructured":"Cohen PA, Jhingran A, Oaknin A, Denny L. Cervical cancer. Lancet. 2019;393(10167):169\u201382.","journal-title":"Lancet"},{"issue":"3","key":"2909_CR2","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"2909_CR3","first-page":"221","volume":"46","author":"RS Zheng","year":"2024","unstructured":"Zheng RS, Chen R, Han BF, Wang SM, Li L, Sun KX, Zeng HM, Wei WW, He J. [Cancer incidence and mortality in china, 2022]. Zhonghua Zhong Liu Za Zhi. 2024;46(3):221\u201331.","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"issue":"1","key":"2909_CR4","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1186\/s12885-024-13376-2","volume":"25","author":"P Zhuoma","year":"2025","unstructured":"Zhuoma P, Cangjue G, Wang H, Qi J. Characteristics and trend analysis of cancer mortality among residents of the Xizang autonomous region, 2014\u20132023. BMC Cancer. 2025;25(1):525.","journal-title":"BMC Cancer"},{"issue":"9895","key":"2909_CR5","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0140-6736(13)60022-7","volume":"382","author":"EJ Crosbie","year":"2013","unstructured":"Crosbie EJ, Einstein MH, Franceschi S, Kitchener HC. Human papillomavirus and cervical cancer. Lancet. 2013;382(9895):889\u201399.","journal-title":"Lancet"},{"issue":"10451","key":"2909_CR6","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S0140-6736(24)01097-3","volume":"404","author":"F Wei","year":"2024","unstructured":"Wei F, Georges D, Man I, Baussano I, Clifford GM. Causal attribution of human papillomavirus genotypes to invasive cervical cancer worldwide: a systematic analysis of the global literature. Lancet. 2024;404(10451):435\u201344.","journal-title":"Lancet"},{"issue":"4","key":"2909_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jinf.2021.02.017","volume":"82","author":"HL Bao","year":"2021","unstructured":"Bao HL, Jin C, Wang S, Song Y, Xu ZY, Yan XJ, Li LM, Ning Y, Wang HJ. Prevalence of cervicovaginal human papillomavirus infection and genotypes in the pre-vaccine era in china: A nationwide population-based study. J Infect. 2021;82(4):75\u201383.","journal-title":"J Infect"},{"issue":"7","key":"2909_CR8","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1002\/cncr.32003","volume":"125","author":"K Li","year":"2019","unstructured":"Li K, Li Q, Song L, Wang D, Yin R. The distribution and prevalence of human papillomavirus in women in Mainland China. Cancer. 2019;125(7):1030\u20137.","journal-title":"Cancer"},{"issue":"1","key":"2909_CR9","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12985-022-01775-5","volume":"19","author":"D Feng","year":"2022","unstructured":"Feng D, Wei S, Chen J, Yu Z, Lhamo Y, Wang H, Zhu X. Human papillomavirus prevalence and genotype distribution landscapes in Shannan city, Tibet Tibetan autonomous region, China. Virol J. 2022;19(1):46.","journal-title":"Virol J"},{"issue":"1","key":"2909_CR10","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1186\/s12879-025-10965-9","volume":"25","author":"D Feng","year":"2025","unstructured":"Feng D, Yao Y, Zhu X, Chen J, Lhamo Y, Baima L, Wang H, Wang Q. Human papillomavirus (HPV) infection and liquid-based cytologic tests among cervical screening participants in Shannan city, tibet, china, during 2021\u20132022. BMC Infect Dis. 2025;25(1):599.","journal-title":"BMC Infect Dis"},{"key":"2909_CR11","doi-asserted-by":"publisher","first-page":"1251440","DOI":"10.3389\/fpubh.2023.1251440","volume":"11","author":"J Li","year":"2023","unstructured":"Li J, Li X, Sheng X. Four-year analysis of high-risk human papillomavirus infection among women in rural areas of Nyingchi city, Tibet. Front Public Health. 2023;11:1251440.","journal-title":"Front Public Health"},{"key":"2909_CR12","doi-asserted-by":"publisher","first-page":"841547","DOI":"10.3389\/fonc.2022.841547","volume":"12","author":"Q Wang","year":"2022","unstructured":"Wang Q, He Y, Long F, Li C, Shen Z, Guo D, Zhaxi D, Bumu L, Hua Z, Sun Z, et al. Cervical cancer screening in high-altitude areas in china: A large cross-section study of 25,173 women in Northern Tibet. Front Oncol. 2022;12:841547.","journal-title":"Front Oncol"},{"issue":"12","key":"2909_CR13","doi-asserted-by":"publisher","first-page":"e996","DOI":"10.1016\/S2468-2667(23)00186-X","volume":"8","author":"C Xia","year":"2023","unstructured":"Xia C, Basu P, Kramer BS, Li H, Qu C, Yu XQ, Canfell K, Qiao Y, Armstrong BK, Chen W. Cancer screening in china: a steep road from evidence to implementation. Lancet Public Health. 2023;8(12):e996\u20131005.","journal-title":"Lancet Public Health"},{"key":"2909_CR14","first-page":"1831","volume":"101","author":"FH Zhao","year":"2021","unstructured":"Zhao FH, Ren WH. [Accelerating the elimination of cervical cancer in China and Building a paradigm for healthy China cancer prevention]. Zhonghua Yi Xue Za Zhi. 2021;101:1831\u20134.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"2","key":"2909_CR15","doi-asserted-by":"publisher","first-page":"e197","DOI":"10.1016\/S2214-109X(22)00501-0","volume":"11","author":"D Singh","year":"2023","unstructured":"Singh D, Vignat J, Lorenzoni V, Eslahi M, Ginsburg O, Lauby-Secretan B, Arbyn M, Basu P, Bray F, Vaccarella S. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO global cervical cancer elimination initiative. Lancet Glob Health. 2023;11(2):e197\u2013206.","journal-title":"Lancet Glob Health"},{"key":"2909_CR16","doi-asserted-by":"publisher","first-page":"28","DOI":"10.25259\/CMAS_03_07_2021","volume":"19","author":"MA Pangarkar","year":"2022","unstructured":"Pangarkar MA. The Bethesda system for reporting cervical cytology. Cytojournal. 2022;19:28.","journal-title":"Cytojournal"},{"issue":"9","key":"2909_CR17","doi-asserted-by":"publisher","first-page":"e1345","DOI":"10.1016\/S2214-109X(23)00305-4","volume":"11","author":"L Bruni","year":"2023","unstructured":"Bruni L, Albero G, Rowley J, Alemany L, Arbyn M, Giuliano AR, Markowitz LE, Broutet N, Taylor M. Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis. Lancet Glob Health. 2023;11(9):e1345\u201362.","journal-title":"Lancet Glob Health"},{"issue":"6","key":"2909_CR18","doi-asserted-by":"publisher","first-page":"e0270670","DOI":"10.1371\/journal.pone.0270670","volume":"17","author":"P Sripan","year":"2022","unstructured":"Sripan P, Pongnikorn D, Chitapanarux I, Tangmunkongvorakul A, Daoprasert K, Aurpibul L, Waisri N, Maneesai P, Wannavongs G, Suwanvanichkij V, et al. Geographical risk pattern and Temporal trends in incidence of HPV-related cancers in Northern thailand: A population-based study. PLoS ONE. 2022;17(6):e0270670.","journal-title":"PLoS ONE"},{"issue":"2","key":"2909_CR19","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1177\/14034948221075410","volume":"51","author":"M Wemrell","year":"2023","unstructured":"Wemrell M, Vicente RP, Merlo J. Mapping sociodemographic and geographical differences in human papillomavirus non-vaccination among young girls in Sweden. Scand J Public Health. 2023;51(2):288\u201395.","journal-title":"Scand J Public Health"},{"issue":"6","key":"2909_CR20","first-page":"969","volume":"10","author":"M Karimi Zarchi","year":"2009","unstructured":"Karimi Zarchi M, Behtash N, Chiti Z, Kargar S. Cervical cancer and HPV vaccines in developing countries. Asian Pac J Cancer Prev. 2009;10(6):969\u201374.","journal-title":"Asian Pac J Cancer Prev"},{"key":"2909_CR21","first-page":"1863","volume":"101","author":"YX Zhao","year":"2021","unstructured":"Zhao YX, Ma L, Ren WH, Song B, Wang LH, Di JL, Wu JL. [Analysis of the reported data of National cervical cancer screening program in rural areas in China from 2009 to 2018]. Zhonghua Yi Xue Za Zhi. 2021;101:1863\u20138.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"5","key":"2909_CR22","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1093\/ajcp\/aqab181","volume":"157","author":"Z Zeng","year":"2022","unstructured":"Zeng Z, Austin RM, Wang L, Guo X, Zeng Q, Zheng B, Zhao C. Nationwide prevalence and genotype distribution of High-Risk human papillomavirus infection in China. Am J Clin Pathol. 2022;157(5):718\u201323.","journal-title":"Am J Clin Pathol"},{"key":"2909_CR23","doi-asserted-by":"publisher","first-page":"4173","DOI":"10.2147\/IDR.S332668","volume":"14","author":"H Yu","year":"2021","unstructured":"Yu H, Yi J, Dou YL, Chen Y, Kong LJ, Wu J. Prevalence and genotype distribution of human papillomavirus among healthy females in beijing, china, 2016\u20132019. Infect Drug Resist. 2021;14:4173\u201382.","journal-title":"Infect Drug Resist"},{"issue":"1","key":"2909_CR24","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12985-021-01518-y","volume":"18","author":"P Li","year":"2021","unstructured":"Li P, Liu Q, Li W, Liu Z, Xing B, Wu S, Zhou Z, Sun L, Ren H, Li H, et al. Characteristics of human papillomavirus infection among women with cervical cytological abnormalities in the Zhoupu district, Shanghai city, china, 2014\u20132019. Virol J. 2021;18(1):51.","journal-title":"Virol J"},{"issue":"1","key":"2909_CR25","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1186\/s12879-024-10011-0","volume":"24","author":"W Guo","year":"2024","unstructured":"Guo W, Hu Z, Yan J, Shen X, Meng Q, Wu H, Xiang Y, Yao C, Du K. Epidemiological study of human papillomavirus infection in 105,679 women in wuhan, China. BMC Infect Dis. 2024;24(1):1111.","journal-title":"BMC Infect Dis"},{"issue":"10","key":"2909_CR26","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/j.jiph.2023.07.013","volume":"16","author":"J Huiyun","year":"2023","unstructured":"Huiyun J, Jie D, Huan W, Yuebo Y, Xiaomao L. Prevalence and characteristics of cervical human papillomavirus genotypes and cervical lesions among 58630 women from guangzhou, China. J Infect Public Health. 2023;16(10):1531\u20136.","journal-title":"J Infect Public Health"},{"issue":"3","key":"2909_CR27","doi-asserted-by":"publisher","first-page":"e244090","DOI":"10.1001\/jamanetworkopen.2024.4090","volume":"7","author":"S Wang","year":"2024","unstructured":"Wang S, Dang L, Liu S, Rezhake R, Yan H, Duan X, Zhang L, Zhang L, Zhang L, Su M, et al. Cervical cancer screening via visual inspection with acetic acid and Lugol iodine for triage of HPV-Positive women. JAMA Netw Open. 2024;7(3):e244090.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"2909_CR28","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12905-019-0785-3","volume":"19","author":"J Wang","year":"2019","unstructured":"Wang J, Tang D, Wang K, Wang J, Zhang Z, Chen Y, Zhang X, Ma C. HPV genotype prevalence and distribution during 2009\u20132018 in xinjiang, china: baseline surveys prior to mass HPV vaccination. BMC Womens Health. 2019;19(1):90.","journal-title":"BMC Womens Health"},{"key":"2909_CR29","doi-asserted-by":"crossref","unstructured":"Hoppe-Seyler K, M\u00e4ndl J, Adrian S, Kuhn BJ, Hoppe-Seyler F. Virus\/Host cell crosstalk in hypoxic HPV-Positive cancer cells. Viruses 2017, 9(7).","DOI":"10.3390\/v9070174"},{"issue":"9","key":"2909_CR30","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/S1470-2045(11)70188-7","volume":"12","author":"PE Castle","year":"2011","unstructured":"Castle PE, Stoler MH, Wright TC Jr., Sharma A, Wright TL, Behrens CM. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study. Lancet Oncol. 2011;12(9):880\u201390.","journal-title":"Lancet Oncol"},{"key":"2909_CR31","first-page":"97","volume":"3","author":"DK Xu","year":"2002","unstructured":"Xu DK. Traditional Tibetan childbearing customs and eugenics analysis. Tibetan Res. 2002;3:97\u2013103.","journal-title":"Tibetan Res"},{"issue":"5","key":"2909_CR32","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1080\/01443615.2019.1634030","volume":"40","author":"KS Okunade","year":"2020","unstructured":"Okunade KS. Human papillomavirus and cervical cancer. J Obstet Gynaecol. 2020;40(5):602\u20138.","journal-title":"J Obstet Gynaecol"},{"issue":"2","key":"2909_CR33","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1086\/524875","volume":"197","author":"RL Winer","year":"2008","unstructured":"Winer RL, Feng Q, Hughes JP, O\u2019Reilly S, Kiviat NB, Koutsky LA. Risk of female human papillomavirus acquisition associated with first male sex partner. J Infect Dis. 2008;197(2):279\u201382.","journal-title":"J Infect Dis"},{"key":"2909_CR34","doi-asserted-by":"crossref","unstructured":"Gravitt PE, Winer RL. Natural history of HPV infection across the lifespan: role of viral latency. Viruses 2017, 9(10).","DOI":"10.3390\/v9100267"},{"issue":"2","key":"2909_CR35","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ijgo.2004.07.013","volume":"87","author":"EM Smith","year":"2004","unstructured":"Smith EM, Johnson SR, Ritchie JM, Feddersen D, Wang D, Turek LP, Haugen TH. Persistent HPV infection in postmenopausal age women. Int J Gynaecol Obstet. 2004;87(2):131\u20137.","journal-title":"Int J Gynaecol Obstet"},{"issue":"6","key":"2909_CR36","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/S0361-090X(03)00104-1","volume":"27","author":"EM Smith","year":"2003","unstructured":"Smith EM, Ritchie JM, Levy BT, Zhang W, Wang D, Haugen TH, Turek LP. Prevalence and persistence of human papillomavirus in postmenopausal age women. Cancer Detect Prev. 2003;27(6):472\u201380.","journal-title":"Cancer Detect Prev"},{"issue":"38","key":"2909_CR37","first-page":"31","volume":"1","author":"K Edwards","year":"2022","unstructured":"Edwards K, Fatehi M, Fogel J. Post-Menopausal status and risk for cervical dysplasia. Gulf J Oncolog. 2022;1(38):31\u20137.","journal-title":"Gulf J Oncolog"},{"issue":"18","key":"2909_CR38","doi-asserted-by":"publisher","first-page":"6896","DOI":"10.1002\/cam4.3296","volume":"9","author":"H Bao","year":"2020","unstructured":"Bao H, Sun X, Zhang Y, Pang B, Li H, Zhou L, Wu F, Cao D, Wang J, Turic B, et al. The artificial intelligence-assisted cytology diagnostic system in large-scale cervical cancer screening: A population-based cohort study of 0.7 million women. Cancer Med. 2020;9(18):6896\u2013906.","journal-title":"Cancer Med"},{"issue":"1","key":"2909_CR39","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1186\/s12905-024-03254-1","volume":"24","author":"S Ezzelarab","year":"2024","unstructured":"Ezzelarab S, El-Husseiny A, Nasreldin M, Ali R, Nabhan A. Cervical cancer screening by cytology and the burden of epithelial abnormalities in low resource settings: a tertiary-center 42-year study. BMC Womens Health. 2024;24(1):405.","journal-title":"BMC Womens Health"},{"issue":"4","key":"2909_CR40","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.jasc.2021.03.006","volume":"10","author":"X Tao","year":"2021","unstructured":"Tao X, Zhang H, Wang S, Chen T, Cong Q, Wang L, Zhou X, Zhao C. Prevalence and carcinogenic risk of high-risk human papillomavirus subtypes in different cervical cytology: a study of 124,251 cases from the largest academic center in China. J Am Soc Cytopathol. 2021;10(4):391\u20138.","journal-title":"J Am Soc Cytopathol"},{"issue":"7","key":"2909_CR41","first-page":"1205","volume":"42","author":"XH Hu","year":"2021","unstructured":"Hu XH, Meng L, Gao YX, Man SLM, Ma Y, Jin C, Wang B, Ning Y, Li LM. [Characteristics of human papillomavirus infection and abnormal cervical cytology in health check-up females in shenzhen]. Zhonghua Liu Xing Bing Xue Za Zhi. 2021;42(7):1205\u201312.","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"2909_CR42","doi-asserted-by":"publisher","first-page":"1123260","DOI":"10.3389\/fcimb.2023.1123260","volume":"13","author":"B Li","year":"2023","unstructured":"Li B, Dong L, Wang C, Li J, Zhao X, Dong M, Li H, Ma X, Dong Y, Wu M, et al. Analysis of the related factors of atypical squamous cells of undetermined significance (ASC-US) in cervical cytology of post-menopausal women. Front Cell Infect Microbiol. 2023;13:1123260.","journal-title":"Front Cell Infect Microbiol"},{"key":"2909_CR43","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ejogrb.2019.06.006","volume":"240","author":"N Kumar","year":"2019","unstructured":"Kumar N, Gupta R, Gupta S. Glandular cell abnormalities in cervical cytology: what has changed in this decade and what has not? Eur J Obstet Gynecol Reprod Biol. 2019;240:68\u201373.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"2909_CR44","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1002\/ijgo.15915","volume":"168","author":"J Cubaka Ntamushigo","year":"2025","unstructured":"Cubaka Ntamushigo J, Motshedisi Sebitloane H. Review of triage strategies for atypical squamous cells of undetermined significance among young women. Int J Gynaecol Obstet. 2025;168(2):428\u201335.","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"2909_CR45","first-page":"307","volume":"13","author":"AMA Abdulaziz","year":"2020","unstructured":"Abdulaziz AMA, Liu L, Sun Y, You X, Cui B, Han S, Zhang Y. Clinicopathologic significance and treatment of ASC-US in cervical cytology. Int J Clin Exp Pathol. 2020;13(2):307\u201316.","journal-title":"Int J Clin Exp Pathol"},{"key":"2909_CR46","doi-asserted-by":"crossref","unstructured":"Ye Y, Jones T, Wang T, Zeng X, Liu Y, Zhao C. Comprehensive overview of genotype distribution and prevalence of human papillomavirus in cervical lesions. Gynecol Obstet Clin Med 2024, 4(1).","DOI":"10.1136\/gocm-2024-000005"},{"key":"2909_CR47","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12985-016-0594-3","volume":"13","author":"TR Martins","year":"2016","unstructured":"Martins TR, Mendes de Oliveira C, Rosa LR, de Campos Centrone C, Rodrigues CL, Villa LL, Levi JE. HPV genotype distribution in Brazilian women with and without cervical lesions: correlation to cytological data. Virol J. 2016;13:138.","journal-title":"Virol J"},{"issue":"1","key":"2909_CR48","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1186\/s12885-021-08703-w","volume":"21","author":"G Zhong","year":"2021","unstructured":"Zhong G, Wang Y, Xie Q, Lin R, Yao T. HPV-specific risk assessment of cervical cytological abnormalities. BMC Cancer. 2021;21(1):949.","journal-title":"BMC Cancer"},{"issue":"1","key":"2909_CR49","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.3802\/jgo.2018.29.e14","volume":"29","author":"YT Ouh","year":"2018","unstructured":"Ouh YT, Min KJ, Cho HW, Ki M, Oh JK, Shin SY, Hong JH, Lee JK. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of korea, 2014\u20132016. J Gynecol Oncol. 2018;29(1):e14.","journal-title":"J Gynecol Oncol"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02909-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-025-02909-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02909-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T01:01:25Z","timestamp":1757379685000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-025-02909-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,13]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2909"],"URL":"https:\/\/doi.org\/10.1186\/s12985-025-02909-1","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,13]]},"assertion":[{"value":"24 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving human participants were reviewed and approved by the Ethics Committee of Shannan Maternal and Child Health Hospital (No. SNFYBJY-202506). The participants provided their written informed consent to participate in this study. All methods were carried out in accordance with Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"279"}}